71894-200Level 3
ITVISMA (onasemnogene abeparvovec-brve)
**Product type:** Human Prescription Drug
**Active ingredient:** ONASEMNOGENE ABEPARVOVEC
**Strength:** 40000000000000 [arb'U]/mL
**Dosage form:** Injection, Suspension
**Route:** Intrathecal
**Labeler:** Novartis Gene Therapies, Inc.
**Marketing category:** BLA (BLA125856)
GET
/api/v1/systems/ndc_fda/nodes/71894-200Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.